Clinical Trials Logo

Alcohol Use Disorder, Severe clinical trials

View clinical trials related to Alcohol Use Disorder, Severe.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05899660 Recruiting - Clinical trials for Alcohol Use Disorder, Severe

Impact of Omega 3 in Alcohol Use Disorder

W3-AUD
Start date: June 19, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the biological pathways underlying the beneficial effect of omega-3 polyunsaturated fatty acids (n-3 PUFA) on mental health in patients with alcohol use disorder. The main questions this study aims to answer are: - Can n-3 PUFA improve mood disorders (depression, anxiety), craving for alcohol, cognitive impairments and sociability disorders ? - Are the beneficial effects of n-3 PUFAs due to a modification of the gut microbiota and/or the inflammatory status? Participants will : - take a supplementation of omega-3 or placebo during 3 months - do a brain MRI - be interviewed for a dietary anamnesis - provide blood, stool and saliva samples - perform psychological tests and neuropsychological tasks Researchers will compare active comparator (omega-3) with placebo comparator (olive oil) to see if omega-3 can have a beneficial effect on AUD patients.